Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, in Healthy Adults in South Africa
Background. The efficacy of bacille Calmette-Guérin (BCG) may be enhanced by heterologous vaccination strategies that boost the BCG-primed immune response. One leading booster vaccine, MVA85A (where "MVA" denotes "modified vaccinia virus Ankara"), has shown promising safety and immunogenicity in... Full description
| 1st Person: | Hawkridge, Tony verfasserin |
|---|---|
| Additional Persons: | Scriba, Thomas J. verfasserin; Gelderbloem, Sebastian verfasserin; Smit, Erica verfasserin; Tameris, Michele verfasserin; Moyo, Sizulu verfasserin; Lang, Trudie verfasserin; Veldsman, Ashley verfasserin; Hatherill, Mark verfasserin; van der Merwe, Linda verfasserin; Fletcher, Helen A. verfasserin; Mahomed, Hassan verfasserin; Hill, Adrian V. S. verfasserin; Hanekom, Willem A. verfasserin; Hussey, Gregory D. verfasserin; McShane, Helen verfasserin |
| Source: |
in The Journal of Infectious Diseases Vol. 198, No. 4 (2008), p. 544-552  More Articles |
| Type of Publication: | Article |
| Language: | English |
| Published: |
2008 |
| Keywords: |
research-article
|
| Online: |
Volltext |
|